Cases 31 - 40 of 76
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Alkem Laboratories Ltd.
as 1:2021cv00992
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Alkem Laboratories Ltd. et al
as 1:2021cv00824
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
as 1:2020cv01286
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
as 1:2020cv01094
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Azurity Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH US, LLC et al v. ALKEM LABORATORIES LTD.
as 3:2020cv02737
Plaintiff:
BAUSCH HEALTH US, LLC, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH AMERICAS, INC. and others
Defendant:
ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Relypsa, Inc. et al v. Alkem Laboratories Ltd. et al
as 1:2020cv00106
Plaintiff:
Vifor (International) Ltd. and Relypsa, Inc.
Defendant:
Alkem Laboratories Ltd. and Ascent Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
